↓ Skip to main content

Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy

Overview of attention for article published in Frontiers in oncology, January 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy
Published in
Frontiers in oncology, January 2021
DOI 10.3389/fonc.2020.589218
Pubmed ID
Authors

Ramiro Vázquez, Maria E. Riveiro, Caroline Berenguer-Daizé, Anthony O’Kane, Julie Gormley, Olivier Touzelet, Keyvan Rezai, Mohamed Bekradda, L’Houcine Ouafik

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 17%
Researcher 5 17%
Student > Bachelor 3 10%
Librarian 1 3%
Student > Master 1 3%
Other 1 3%
Unknown 14 47%
Readers by discipline Count As %
Medicine and Dentistry 4 13%
Biochemistry, Genetics and Molecular Biology 4 13%
Agricultural and Biological Sciences 3 10%
Neuroscience 2 7%
Mathematics 1 3%
Other 4 13%
Unknown 12 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2023.
All research outputs
#8,674,193
of 25,707,225 outputs
Outputs from Frontiers in oncology
#3,437
of 22,767 outputs
Outputs of similar age
#205,785
of 529,065 outputs
Outputs of similar age from Frontiers in oncology
#118
of 650 outputs
Altmetric has tracked 25,707,225 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,767 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 529,065 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 650 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.